ISCN 1991 : guidelines for cancer cytogenetics : supplement to An international system for human cytogenetic nomenclature : recommendations of the Standing Committee on Human Cytogenetic Nomenclature, Subcommittee on Cancer Cytogenetics
Author(s)
Bibliographic Information
ISCN 1991 : guidelines for cancer cytogenetics : supplement to An international system for human cytogenetic nomenclature : recommendations of the Standing Committee on Human Cytogenetic Nomenclature, Subcommittee on Cancer Cytogenetics
Karger, c1992
Available at 5 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Description and Table of Contents
Description
The immense amounts of new data accumulated on neoplasia-associated chromosome aberrations have revealed certain inadequacies in the system now used universally to describe tumour karyotypes. Consequently, the Standing Committee on Human Cytogenetic Nomenclature decided to establish new guidelines to avoid confusion in the literature and to improve communication among scientists. This report proposes recommendations and simple, uniform guidelines for the description of most acquired clonal karyotypic abnormalities. The guidelines are based on normal chromosomes and constitutional chromosome aberrations (ISCN 1985). However, the definitions of some terms have been slightly modified and some new terms describing aberrations found primarily in neoplastic cells have been added. Approved by the ISCN Standing Committee, the report incorporates and supersedes all previous ISCN recommendations on cancer cytogenetics in man. The Committee recommends that this nomenclature system also be used in the description of acquired chromosome aberrations in neoplasms of other species.
Table of Contents
- General considerations
- modal number
- clones and clonal evolution
- order of chromosome abnormalities in the karyotype
- constitutional karyotype
- numerical chromosome abnormalities
- structural chromosome abnormalities
- specification of chromosome rearrangements
- marker chromosomes
- multiple copies of rearranged chromosomes
- uncertainty in chromosome or bank designation
- members of the ISCN Standing Committee and Subcommittee.
by "Nielsen BookData"